THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 91 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,529,000 | -10.3% | 155,690 | +1.2% | 0.00% | -33.3% |
| Q4 2018 | $3,935,000 | -56.9% | 153,769 | -45.0% | 0.01% | 0.0% |
| Q3 2018 | $9,136,000 | +272.1% | 279,630 | +158.3% | 0.01% | +100.0% |
| Q2 2018 | $2,455,000 | -4.1% | 108,263 | +2.5% | 0.00% | 0.0% |
| Q1 2018 | $2,561,000 | -10.7% | 105,605 | +2.7% | 0.00% | -25.0% |
| Q4 2017 | $2,867,000 | -18.5% | 102,788 | +0.0% | 0.00% | -20.0% |
| Q3 2017 | $3,518,000 | -14.6% | 102,757 | -0.6% | 0.01% | -16.7% |
| Q2 2017 | $4,118,000 | +39.6% | 103,358 | +29.0% | 0.01% | +50.0% |
| Q1 2017 | $2,950,000 | +33.0% | 80,113 | +15.2% | 0.00% | +33.3% |
| Q4 2016 | $2,218,000 | +4.9% | 69,563 | +19.2% | 0.00% | -25.0% |
| Q3 2016 | $2,115,000 | +59.7% | 58,362 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $1,324,000 | +41.3% | 58,362 | +17.1% | 0.00% | 0.0% |
| Q1 2016 | $937,000 | +23.0% | 49,857 | +7.2% | 0.00% | +100.0% |
| Q4 2015 | $762,000 | +85.0% | 46,489 | +23.9% | 0.00% | 0.0% |
| Q3 2015 | $412,000 | -15.6% | 37,508 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $488,000 | -14.5% | 37,508 | +13.9% | 0.00% | 0.0% |
| Q1 2015 | $571,000 | +16.3% | 32,920 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $491,000 | -35.3% | 32,920 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $759,000 | -27.6% | 32,920 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,049,000 | – | 32,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
| Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
| Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
| Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
| Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
| CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
| Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
| King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
| Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
| PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |